Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02112188Active Not Recruiting

Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer

Role: collaborator

NCT03276559Not ApplicableCompleted

Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients

Role: collaborator

NCT02299414Phase 4Completed

Chronic Hypertension and Pregnancy (CHAP) Project

Role: collaborator

NCT05130541Not ApplicableCompleted

Proning Early in Awake COVID-19 Hypoxic Respiratory Failure (PREACHR) Study

Role: lead

NCT01082900Not ApplicableCompleted

Prophylactic Continuous Positive Airway Pressure (CPAP) in Delivery Room, in the Prevention of Transient Tachypnea of Newborn (TTN): A Randomized Controlled Trial

Role: lead

NCT02052986Phase 2Unknown

An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels

Role: lead

NCT01623297Unknown

Confusion in the Elderly After Colon Surgery

Role: lead

All 7 trials loaded